GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Rua Bioscience RUA.NZ · NZD

Health Care · NZX · 🇳🇿 New Zealand

Compare

0.03

—

Close of 9 Nov 2026, in NZD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in NZD, from our data supplier.

FY2025

Revenue

NZD 1.5m

FY2019FY2025

Net income

−NZD 3.5m

FY2019FY2025

Free cash flow

−NZD 2.8m

FY2019FY2025

Shareholders' equity

NZD 4.9m

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
RevenueNZD 1.5mNZD 85,800NZD 357,700NZD 24,200———
Gross profitNZD 534,800−NZD 118,300NZD 18,100−NZD 104,400———
Research and developmentNZD 944,800NZD 1.2mNZD 1.6mNZD 3.0mNZD 1.9mNZD 1.3mNZD 818,700
Operating income−NZD 3.3m−NZD 4.6m−NZD 12.0m−NZD 7.6m−NZD 6.3m−NZD 3.6m−NZD 2.0m
Net income−NZD 3.5m−NZD 13.7m−NZD 6.0m−NZD 8.6m−NZD 4.4m−NZD 2.8m−NZD 2.0m
Diluted earnings per share-0.02-0.07-0.03-0.05-0.03-0.02-0.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assetsNZD 6.8mNZD 7.7mNZD 21.0mNZD 33.6mNZD 30.9mNZD 15.7mNZD 11.1m
Cash and short-term investmentsNZD 241,400NZD 895,100NZD 4.6mNZD 9.9mNZD 16.4mNZD 3.9mNZD 6.2m
Total liabilitiesNZD 1.9mNZD 973,100NZD 830,300NZD 9.4mNZD 2.0mNZD 1.3mNZD 621,600
DebtNZD 804,000NZD 147,800NZD 114,600NZD 824,000NZD 954,800NZD 348,800NZD 216,800
Shareholders' equityNZD 4.9mNZD 6.8mNZD 20.1mNZD 24.2mNZD 28.8mNZD 14.4mNZD 10.5m
Shares outstanding200m192m187m170m127m140m140m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations−NZD 2.8m−NZD 3.7m−NZD 5.9m−NZD 6.8m−NZD 4.4m−NZD 3.6m−NZD 2.0m
Capital spending−NZD 3,400−NZD 1,200−NZD 73,800−NZD 400,100−NZD 1.4m−NZD 5.0m−NZD 455,100
Free cash flow−NZD 2.8m−NZD 3.7m−NZD 6.0m−NZD 7.2m−NZD 5.8m−NZD 8.6m−NZD 2.4m

Latest quarters

By quarter end

Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022Jun 2022Dec 2021
RevenueNZD 817,500NZD 693,800NZD 68,900NZD 17,000NZD 294,900NZD 62,800NZD 24,200—
Gross profitNZD 327,600NZD 207,200−NZD 115,000−NZD 3,300NZD 77,500−NZD 59,400−NZD 104,400—
Operating income−NZD 1.5m−NZD 1.6m−NZD 2.3m−NZD 2.3m−NZD 8.5m−NZD 3.5m−NZD 4.1m−NZD 3.5m
Net income−NZD 1.7m−NZD 1.8m−NZD 2.9m−NZD 10.9m−NZD 6.7mNZD 718,700−NZD 6.2m−NZD 2.5m
Diluted earnings per share-0.01-0.01-0.01-0.06-0.040.00-0.04-0.02
Total assetsNZD 6.8mNZD 7.7mNZD 7.7mNZD 10.0mNZD 21.0mNZD 29.1mNZD 33.6mNZD 28.0m
Cash and short-term investmentsNZD 241,400NZD 538,700NZD 895,100NZD 2.5mNZD 4.6mNZD 6.8mNZD 9.9mNZD 12.3m
DebtNZD 763,200NZD 461,600NZD 99,100NZD 124,000NZD 67,900NZD 123,000NZD 695,500NZD 750,900
Shareholders' equityNZD 4.9mNZD 6.3mNZD 6.8mNZD 9.5mNZD 20.1mNZD 26.7mNZD 24.2mNZD 26.5m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue296.7%——
Operating income-24.0%-1.6%—
Net income-26.3%4.2%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin26.1%16.7%——
Operating margin-497.7%-1390.8%——
Net margin-1075.4%-1605.3%——

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings-1.6-0.4-3.8-4.2-12.7-29.9
Price to sales3.765.062.6———

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.